Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-25 @ 4:13 AM
NCT ID:
NCT00751920
Eligibility Criteria:
Inclusion Criteria:
* Patients between 2-18 years of age
* Patients who present themselves to the Department of Diagnostic Imaging at the Hospital for Sick Children for CT of the thorax
* Patients undergoing a CT of the thorax for detection of lung metastases following diagnosis of a solid tumor or suspected solid tumor
* Patients who present themselves for initial diagnosis or at follow up CT for progression
* Able to give informed consent (parents or patients)
Exclusion Criteria:
* Usual exclusion criteria for MRI (e.g. pacemaker, ocular metal, claustrophobia)
* Have any known allergy to one or more of the ingredients in the study contrast agents; have a history of hypersensitivity to any metals or chelates of gadolinium; have a history of allergies or bronchial asthma; use beta blockers, have cardiovascular disease; or have anaphylactic reactions
* Have moderate-to-severe renal impairment (defined as having a GFR/ eGFR \< 60 mL/min)
* Have sickle cell anemia
* MRI of the chest requiring sedation or general anesthesia
* Known pregnancy or breast feeding
* Renal failure
* Patient uncooperative during a MRI without sedation or anesthesia (unless already receiving this for MRI of another body region)
* Children under the age of 2 will not be eligible for intravenous contrast
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
18 Years
Study:
NCT00751920
Study Brief:
Protocol Section:
NCT00751920